Recursion Pharmaceuticals, Inc. Share Price
Equities
RXRX
US75629V1044
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.320 USD | +1.53% |
|
-2.06% | -18.83% |
| Capitalization | 1.76B 1.5B 1.37B 1.29B 2.41B 166B 2.43B 16.25B 6.34B 79.94B 6.61B 6.47B 276B | P/E ratio 2026 * |
-3.79x | P/E ratio 2027 * | -3.84x |
|---|---|---|---|---|---|
| Enterprise value | 1.44B 1.23B 1.12B 1.06B 1.97B 136B 1.99B 13.3B 5.19B 65.43B 5.41B 5.3B 226B | EV / Sales 2026 * |
21.9x | EV / Sales 2027 * | 12x |
| Free-Float |
96.72% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Recursion Pharmaceuticals, Inc.
| 1 day | +1.53% | ||
| 1 week | -2.06% | ||
| Current month | -4.05% | ||
| 1 month | +0.30% | ||
| 3 months | -16.58% | ||
| 6 months | -28.14% | ||
| Current year | -18.83% |
| 1 week | 3.14 |  | 3.56 |
| 1 month | 3.14 | | 3.9 |
| Current year | 2.8 | | 5.24 |
| 1 year | 2.8 | | 7.18 |
| 3 years | 2.8 | | 16.74 |
| 5 years | 2.8 | | 42.81 |
| 10 years | 2.8 | | 42.81 |
| Manager | Title | Age | Since |
|---|---|---|---|
Najat Khan
CEO | Chief Executive Officer | 43 | 31/12/2025 |
Ben Taylor
DFI | Director of Finance/CFO | 48 | 19/11/2024 |
Vicki Goodman
CTO | Chief Tech/Sci/R&D Officer | 57 | 05/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Blake Borgeson
BRD | Director/Board Member | 44 | 03/11/2013 |
| Chairman | 43 | 31/12/2025 | |
Dean Li
BRD | Director/Board Member | 62 | 03/11/2013 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.53% | -2.06% | -23.33% | -42.36% | 1.76B | |
| -0.06% | +0.42% | +35.24% | +84.59% | 49.1B | |
| -4.03% | -2.51% | +80.83% | +60.63% | 47.65B | |
| +1.19% | -3.50% | +1.46% | -10.08% | 23.8B | |
| -3.48% | -23.95% | +55.73% | +435.39% | 21.97B | |
| -1.86% | -1.15% | +41.39% | -27.50% | 17.26B | |
| -6.65% | -3.10% | +24.45% | -38.98% | 15.88B | |
| -2.83% | -1.33% | +58.86% | +208.05% | 15.77B | |
| +5.42% | +12.19% | -24.54% | +841.67% | 14.03B | |
| -1.71% | -4.73% | +39.31% | - | 13.32B | |
| Average | -1.25% | -3.12% | +28.94% | +167.93% | 22.05B | |
| Weighted average by Cap. | -1.68% | -3.46% | +40.85% | +146.17% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 65.73M 55.85M 51.11M 48.24M 89.99M 6.21B 90.78M 606M 236M 2.98B 247M 241M 10.3B | 123M 104M 95.53M 90.17M 168M 11.6B 170M 1.13B 442M 5.57B 461M 451M 19.24B |
| Net income | -462M -393M -359M -339M -633M -43.66B -638M -4.26B -1.66B -20.97B -1.73B -1.7B -72.4B | -466M -396M -362M -342M -638M -44B -643M -4.3B -1.68B -21.14B -1.75B -1.71B -72.97B |
| Net Debt | -320M -272M -249M -235M -438M -30.2B -442M -2.95B -1.15B -14.51B -1.2B -1.17B -50.08B | -287M -243M -223M -210M -392M -27.07B -396M -2.64B -1.03B -13B -1.08B -1.05B -44.88B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/05/26 | 3.320 $ | +1.53% | 13,648,215 |
| 07/05/26 | 3.270 $ | -4.66% | 12,063,436 |
| 06/05/26 | 3.430 $ | +1.78% | 17,691,358 |
| 05/05/26 | 3.370 $ | -4.26% | 13,484,742 |
| 04/05/26 | 3.520 $ | +3.83% | 10,360,005 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- RXRX Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition